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ABSTRACT 
 
 
 
 Estrogenic compounds have been found in surface waters downstream from 
wastewater treatment plant effluents. In the aquatic environment, these hormones are 
shown to cause feminization and sterility of aquatic organisms, thus altering aquatic 
ecosystems upon which human health depends.  In order to assess estrogenic compounds 
at a local wastewater treatment facility in Franklin, KY, Environmental Protection 
Agency Method 539 [Determination of Hormones in Drinking Water by Solid Phase 
Extraction (SPE) and Liquid Chromatography Electrospray Ionization Tandem Mass 
Spectrometry (LC/ESI-MS/MS)] was modified to measure levels of these contaminants 
in wastewater influent and effluent.  This method requires use of LC/ESI-MS/MS 
analysis. A significant matrix effect occurred in the analysis due to ion suppression in 
influent samples. Evaluation of the analyses completed showed that only the hormone 
estrone was successfully extracted and detected in influent and effluent samples.  
Statistical analysis of these results showed a significant decrease in estrone in the effluent 
as compared to the influent.  Based on this comparison, the wastewater treatment process 
utilized by the City of Franklin, KY has the capacity to remove estrone from influent 
wastewater. The presence of BPA was confirmed in all influent, effluent, and blank 
samples. Further studies should be conducted to identify the treatment modality that is 
effective in removing estrone and other hormones during the wastewater treatment 
process.  A final conclusion is that an alternative method of extraction should be 
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developed to determine the presence of estrogens in wastewater, avoid a matrix effect, 
and eliminate ion suppression.  
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
Background 
 
The increased use of estrogen containing pharmaceuticals has led to the detection 
of these contaminants in surface waters (Brooks, Riley, & Taylor, 2006; Zhang, Zhang, 
Zhang, Luo, & Yan, 2012).  Estrogenic compounds may enter the environment from 
wastewater treatment plants (WWTP), due to concentrations in sewage (Clouzot, Marrot, 
Doumenq, & Roche, 2008). Currently, there is no standard for safe levels of estrogen to 
be discharged into surface waters from WWTP effluents.   
WWTPs have the ability to filter contaminants, chemicals and particulates; 
therefore it is possible that some processes within a WWTP remove levels of estrogenic 
compounds from wastewater influent. Previous studies indicate that treatment in WWTPs 
does not remove estrogenic compounds (Clouzot, Marrot, Doumenq, & Roche, 2008). 
However, data comparing estrogen levels before and after treatment is limited. It has 
been documented that biological effects in aquatic organisms can be lessened through 
improved WWTPs (Barber, Vajda, Douville, Norris, & Writer, 2012). 
WWTPs are considered point sources for conventional and emerging 
contaminants.  In this case, estrogenic compounds are considered to be emerging 
contaminants that are not currently regulated by National Pollutant Discharge Elimination 
System (NPDES) permits. In these situations, it is “acknowledged that human exposure 
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to environmental pharmaceuticals is below mammalian therapeutic levels,” (Brooks, 
Riley and Taylor, 2006) however aquatic organisms can be greatly affected. Non-point 
sources of pharmaceutical exposure do not pose as great a risk as point source exposure 
(Brooks, Riley and Taylor, 2006). Point source exposure from a WWTP effluent occurs 
in great amounts over an extended period of time. Non-point source exposure often 
results after episodic precipitation events, which may introduce limited amounts of 
estrogenic compounds over a short period of time. While both sources can result in 
pharmaceuticals leaching into streams, point sources are the greatest concern (Brooks, 
Riley and Taylor, 2006).  
Estrogen containing pharmaceuticals are some of the most widely prescribed 
medications in the United States. These medications are used for a variety of health 
reasons, including contraception, treatment for menopausal symptoms and osteoporosis 
prevention (Ruggiero and Likis, 2010). As a result of the widespread use of these drugs, 
estrogens entering surface waters have become a serious concern. Pharmaceutical 
estrogens are metabolized in the human body before being excreted in feces and urine. 
Then these estrogen remnants enter WWTP influents via sewage line, travel through the 
treatment plants and then are deposited into surface waters in WWTP effluents (Clouzot, 
et al., 2008). Estrogens have been detected in trace concentrations, yet these 
concentrations may be biologically active in the ecosystem, and contribute to 
estrogenicity of surface waters (Clouzot, et al., 2008).  
In the environment, the main concern is that estrogens act as endocrine disrupting 
chemicals (EDCs), defined as “an exogenous substance that causes adverse health effects 
in an intact organism, or its progeny, secondary to changes in endocrine functions. EDCs 
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can be a variety of chemicals including pesticides, alkylphenols, natural and synthetic 
hormones. Natural estrogenic ECDs that can be found in the environment are estrone, 
17α-estradiol, estriol (Clouzot, et al., 2008). One of the most concerning EDCs is 17α-
ethinylestradiol (EE2), a synthetic estrogen, most commonly found in oral contraceptives 
(Brooks, Riley, & Taylor, 2006). EE2 is responsible for 35-50 percent of surface water 
estrogenicity according to Clouzot, et al. (2008).  
Some of the noticeable consequences of EE2 exposure include feminization of 
aquatic organisms and the development of intersex fish. Results include testes 
malformation and oocytes developing within testes (Clouzot, et al., 2008). Further studies 
have concluded that EE2 can be toxic and cause long term effects in aquatic 
environments (Carlsson, et al., 2006). Food web models have also demonstrated the 
potential bioaccumulation of EE2 in fish (Lai, Scrimshaw & Lester, 2002). 
Xenobiotic EE2 has an additional ethinyl group at the C17 location of the 
molecule, which makes it more resistant to biodegradation than natural hormones 
(Clouzot, et al., 2008). Of the hormones, EE2 has the greatest potential sorption ability 
and has a half-life between 20 and 40 days, as compared to estradiol which has a half-life 
of one day (Jurgens, et al., 2002). EE2 can also be adsorbed on sediments and persist in 
anaerobic conditions as it is not easily biodegraded (Jurgens, et al., 2002).  As a result, 
EE2 is more likely to affect ecosystem health as it persists longer in the environment than 
natural estrogens. Therefore, removal of estrogenic compounds via wastewater treatment 
is a first order barrier to ensure protection of public health. 
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Study Objectives 
 An analytical method utilizing solid phase extraction and liquid chromatography 
electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) was applied to 
assess concentrations of estrogenic compounds before and after treatment, in influent and 
effluent.  The focus of this study was to determine whether or not conventional WWTP 
practices removed levels of estrogenic compounds from wastewater influent as compared 
to effluent discharged into the environment.  This is of great importance as impacts to 
ecosystem health have direct consequences for human health. 
 Therefore, the primary study objective was to assess if levels of estrogenic 
compounds in wastewater effluent were significantly less than concentrations found in 
WWTP influent.  A secondary objective was to evaluate the use of a modified version of 
EPA Method 539 as applied to analysis of hormones in WWTP influent and effluent.  
Method 539 was modified by implementing an additional filtration and extraction step.   
 Based upon these objectives the null hypothesis for this study is as follows: 
H0: There will be no difference in concentrations of estrogenic compounds measured to 
occur in the Franklin, KY WWTP influent as compared to the effluent.  Likewise the 
alternate hypothesis may be stated as: Ha = There will be a significant difference in 
concentrations of estrogenic compounds measured to occur in the Franklin, KY WWTP 
influent as compared to the effluent.  
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CHAPTER 2 
 
 
METHODOLOGY 
 
 
 Data for this study were developed through analysis of influent and effluent 
samples from the wastewater treatment plant in Franklin, Kentucky.  Influent samples 
were collected from wastewater entering the plant. Effluent samples were collected from 
treated water being discharged from the plant. This facility is located in Franklin, KY as 
shown in Figure 3.1. This WWTP is classified as an extended aeration system .Within 
this system, microscopic organisms are used to break down organic materials to clean the 
wastewater. This is done by carefully adding the correct ratios of air, nutrients and 
organic material to the microorganisms, in order for them to do their intended job 
(“Wastewater treatment plant”). 
 
Franklin, KY WWTP 
 During the study, wastewater was collected at the Franklin, KY WWTP This 
facility receives influent from sanitary sewer collection points in the City and Simpson 
County. Influent wastewater first flows through a screen system for removal of larger 
solid wastes. Next, contaminants were first removed through a degreasing and de-gritting 
process.  The wastewater was then contained in large holding pools where it is slowly 
circulated in order for larger materials to settle to the bottom of the clarifier. Then, 
microorganisms are used to remove the remaining organic materials in the aerated 
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activated sludge basins. Next, treated wastewater from the basins is routed to a final 
clarifier for settling of solids.  Following decanting of liquid from the final clarifiers,  
chlorine was added to the wastewater for disinfection. Then, the water is dechlorinated in  
 
Figure 2.1. Location of the WWTP in Franklin, KY. 
 
a contact basin, so that a large amount of chlorine is not introduced into the effluent. 
However, this process destroys microorganisms in the effluent and is not designed 
remove all contaminants from wastewater, such as pharmaceuticals and personal care 
products.  
 
Modification of EPA Method 539 
 EPA Method 539 is for the determination of hormones in drinking water through 
the use of solid phase extraction (SPE) and liquid chromatography electrospray ionization 
tandem mass spectrometry (LC/ESI-MS/MS). Drinking water contains less particulate 
matter than surface waters and wastewater. Therefore, this method had to be modified to 
fit the criteria of this study. According to the method, modifications are permitted. These 
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modifications include LC columns, LC conditions, internal standards, surrogate 
standards, MS and MS/MS conditions.  
 This method calls for the use of two preservation reagents: sodium thiosulfate and 
2-mercaptopyridine-1-oxide, sodium salt. Sodium thiosulfate is used to remove free 
chlorine. The last step of the wastewater treatment process before the water is released in 
the effluent is dechlorination. Therefore, these samples did not contain chlorine, unlike 
the drinking water that this method was designed to analyze. Only 2-mercaptopyridine-1-
oxide, sodium salt was used as a preservative to inhibit microbial growth.  
 Sold phase extraction discs are much too fine to allow liquid from the wastewater 
influent to filter through, while retaining the solid particles. As a result, a pre filtering 
step was added to this method. This step used extraction glassware on a vacuum 
manifold, similar to the SPE step. However, a filter was used to remove nonorganic 
particles from the influent wastewater, rather than the SPE disc being used to collect 
organic materials. The original method states, “It is highly recommended that all samples 
be filtered prior to analysis.” (EPA Method 539). Further, the method approves filtering 
as a part of sample preparation.  
 This method also calls for the use of surrogates in each sample. These surrogates 
are bisphenol A-d16 and ethynylestradiol-d4.  Instead, 4-androstene-3,17-dione, equilin, 
17-beta-estradiol, estriol, estrone, 17-alpha-ethynylestradiol and  testosterone, were used 
as surrogates in 4 samples and 5 laboratory control spiked blanks. This was deliberately 
done to avoid the potential health risks associated with bisphenol-A. These surrogates are 
normally used as internal standards. However, this study utilized them as surrogates so 
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that percent recovery and validation of the method and extraction could be easily 
determined.  
 
Sample Collection & Preparation 
Samples for analysis of estrogenic compounds were collected July 2014 through 
February 2015 at the Franklin, Kentucky WWTP. These sets of grab samples included 
one from the influent wastewater, one from the treated effluent wastewater, a duplicate of 
the treated effluent wastewater and a blank (Table 3.1). All samples were collected in 
1000 ml amber glass bottles and preserved with 65 mg of 2-mercaptopyridine-1-oxide 
sodium salt to prevent microbial degradation.  
 Three treated effluent duplicates (F003, F033, F053), one influent duplicate 
(F0311) and five blank samples (F004, F024, F034, F044, F054), which then became 
laboratory controlled spikes (LCSs), were then fortified with 2 μL of a surrogate, capped, 
and inverted to mix. This surrogate was a combination of hormones in acetonitrile (Table 
3.2). 
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Table 2.1. Samples collected at the Franklin, KY WWTP during the study period. 
 
Sample Type Influent 
Influent 
Duplicate 
Effluent 
Effluent 
Duplicate 
Blank 
Number of 
Samples 
8 2 8 6 5 
Sample ID 
F001, F021, 
F031, F041, 
F051, F061, 
F071, F081 
F0311, F0312 
F002, F022, 
F032, F042, 
F052, F062, 
F072, F082 
F003, F023, 
F033, F043, 
F053, F063, 
F004, F024, 
F034, F044, 
F054 
 
 
 
Table 2.2. Surrogate compounds added to fortified samples for spike recovery and matrix 
evaluation. 
Hormone Concentration 
4-Androstene-3, 17-dione 100 μg/ml 
Equilin 200 μg/ml 
17-beta-Estradiol 250 μg/ml 
Estriol 200 μg/ml 
Estrone 200 μg/ml 
17-alpha-Ethynylestradiol 350 μg/ml 
Testrosterone 100 μg/ml 
 
 
Influent samples were filtered before extraction due to the large amounts of 
particulate matter present in the samples. A water vacuum manifold was used to filter 
influent samples through a 47 mm glass fiber filter disk. The filter disk was placed on a 
screen between the funnel and base of the vacuum manifold. Disks were cleaned using 15 
ml of methanol. The methanol was drawn through the disk until dry. Then, the disk was 
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conditioned using 10 ml of methanol. One ml of the solvent was pulled through the disk, 
then soaked for one minute before the rest of the solvent was drawn through the disk. 
Lastly, the disk was conditioned with 10 ml of reagent water. One ml was pulled through 
the disk, and the disk was soaked in the remaining liquid for one minute before being 
pulled through.  
To complete the critical step of solid phase extraction (SPE) a sample would be 
filtered through a 47 mm diameter SPE disk, manufactured with octadecyl (C18) sorbent 
phase.  The SPE disk would be mounted on vacuum extraction manifold then a sample 
would be added on top of the filter in the manifold. To complete extraction the water 
vacuum was turned on and the sample was filtered through the disk. Following filtration, 
the sample container was rinsed with 10 ml of 15% methanol to remove any additional 
organic material. Then a vacuum was pulled on the SPE disk for an additional10 minutes.  
Once SPE was completed for a sample, the organic material, estrogenic 
compounds, had to be concentrated by elution from the filter disk.  To accomplish 
elution, 5 ml of methanol was added to the funnel on top of the filter. One ml was 
allowed to pass through the disk before soaking for one minute. After the soaking phase, 
the rest of the methanol was pulled through the SPE disk. This process was repeated two 
additional times for a total of 15 ml of methanol elutrant. 
Effluent samples were extracted using a similar method as above. However, a pre-
SPE step that consisted of filtering the sample through a glass fiber filter to remove solids 
was not employed, as the effluent samples were much less turbid. The same SPE process 
on effluent samples, as previously described.. This SPE method was also used for 
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duplicates and blanks, as these samples did not contain excessive amounts of particulate 
matter.  
After samples were extracted to a volume of 15 ml, all samples were concentrated 
to dryness at the WKU Advanced Materials Institute laboratory with a nitrogen blow 
down unit. Samples were placed in a warm water bath, at about 40°C with a gentle 
stream of nitrogen blowing across them. Once the samples were concentrated to dryness 
they were taken to the University of Kentucky for analysis.  
 
Sample Storage 
 As per EPA Method 539, samples were chilled during transportation from the 
Franklin WWTP to the Environmental Science laboratory at WKU. Each sample did not 
exceed 10°C during the first 48 hours after collection while in storage in the laboratory. 
Samples were extracted within 28 days of collection and analyzed within 28 days of 
extraction. Once extracted, samples did not exceed 0°C. The samples were never frozen 
and were protected from light.  
 
 
Sample Analysis 
 After arriving at the Environmental Research Training Laboratory at the 
University of Kentucky, each sample was reconstituted to a volume of 1 ml using 50% 
methanol and 50% water, each containing 0.1% formic acid. This solution also contained 
1000 ppb of ethinylestradiol-d4 as an internal standard. Samples were analyzed using 
LC/ESI-MS/MS. A Gemini C18 LC column was used in the analysis. Proper conditions 
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were created through a calibration of known standards, which included ethinylestradiol, 
estrone, and estriol. The LC/ESI-MS/MS was calibrated using various concentrations of 
the surrogate, adjusted for the concentrations of estrone  (200 μg/ml), equilin (200 
μg/ml), and ethinylestradiol (350 μg/ml) (Appendix A).  Standards for these compounds 
were created from 1 to 1000 ppb for estrone and equilin, and 1.75 to 1750 ppb for EE2 
(Table 3) (Appendix B). The instrument detection limit was 5 ppb for estrone and equilin 
and 8.75 ppb for EE2.   Samples were introduced into the LC/ESI-MS/MS and analyzed 
according to EPA Method 539. 
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Table 2.3. Internal standards developed for calibration. 
Hormone Standard Concentration  (ppb) 
Estrone 1 
Estrone 5 
Estrone 10 
Estrone 100 
Estrone 500 
Estrone 1000 
Equilin 1 
Equilin 5 
Equilin 10 
Equilin 100 
Eqilin 500 
Equilin 1000 
EE2 1.75 
EE2 8.75 
EE2 17.5 
EE2 175 
EE2 875 
EE2 1750 
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CHAPTER 3 
 
 
RESULTS 
 
 
The previously indicated internal standards were analyzed in order to calibrate the 
instrument (Appendix B). A standard was also analyzed before, in the middle, and at the 
end of the sample set to continually check the calibration of the LC/ESI-MS/MS 
(Appendix C). 
Table 6.1 summarizes the results from the analysis of samples with the LC/ESI-
MS/MS.  Results shown are the concentrations of equilin, estrone, EE2, and the internal 
standard detected in the samples by the LC/ESI-MS/MS.  
 
Laboratory Controlled Spikes 
 The blank samples collected that were fortified with the surrogate became 
laboratory controlled spikes (LCS). These samples are used to determine percent 
recovery and the effectiveness of the extraction method.  Each LCS was fortified with 2 
μl of the surrogate. Surrogate concentrations injected into each sample contained 200 
μg/μl of equilin and estrone, as well as 350 μg/μl of EE2, each of these samples were 
spiked with 400 ppb of equlin, 400 pbb of estrone, and 700 ppb of EE2.  
 According to EPA Method 539, demonstration of accuracy can be shown through 
percent recovery of surrogates by using the following formula: 
% Recovery = 
Average Measured Concentration
Fortified Concentration
 x 100 
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Table 3.1. Results for samples analyzed by LC/ESI-MS/MS during the study.  
Sample ID Estrone (ppb) Equilin (ppb) EE2 (ppb) 
Internal Standard 
(ppb) 
F001 19.055 < 1.0 ** < 8.75** 1000 
F002 8.902 < 1.0 ** < 8.75** 1000 
F003 111.141 130.997 98.410 1000 
F004 372.643 399.417 723.602 1000 
F021 14.441 < 1.0 ** < 8.75** 1000 
F022 < 1.0 ** < 1.0 ** < 8.75** 1000 
F023 < 1.0 ** < 1.0 ** < 8.75** 1000 
F024 386.731 435.837 683.455 1000 
F031 14.122 < 1.0 ** < 8.75** 1000 
F0311 631.070 494.698 771.846 1000 
F0312 < 1.0 ** < 1.0 ** < 8.75** 1000 
F032 < 1.0 ** < 1.0 ** < 8.75** 1000 
F033 331.247 282.220 547.865 1000 
F034 257.562 317.202 536.488 1000 
F041* 41.488 < 1.0 ** < 8.75** 1000 
F042 3.886 < 1.0 ** < 8.75** 1000 
F043 < 1.0 ** < 1.0 ** < 8.75** 1000 
F044 344.012 380.286 643.560 1000 
F051* 14.346 < 1.0 ** < 8.75** 1000 
F052 8.091 < 1.0 ** < 8.75** 1000 
F053 432.211 343.683 639.840 1000 
F054 367.651 384.076 659.426 1000 
F061* 121.783 < 1.0 ** < 8.75** 1000 
F062 17.711 < 1.0 ** < 8.75** 1000 
F063 12.824 < 1.0 ** < 8.75** 1000 
F064 < 1.0 ** < 1.0 ** < 8.75** 1000 
F071* < 1.0 ** < 1.0 ** < 8.75** 1000 
F072 < 1.0 ** < 1.0 ** < 8.75** 1000 
F081* < 1.0 ** < 1.0 ** < 8.75** 1000 
F082 < 1.0 ** < 1.0 ** < 8.75** 1000 
*A visible matrix effect was present causing instrument defect. This can be seen through the area of the 
internal standard curves from the MS/MS. All MS/MS report sheets are shown in Appendix D. 
** Less than the limit of detection for the study per method and LC/ESI-MS/MS utilized. 
 
 
Below is the percent recovery results for each analyte. These results were within 
acceptable limits as specified in EPA Method 539.  Percent recovery for spiked samples 
was 95.8%, 86.4%, and 92.8%, for equilin, estrone, and EE2, respectively. 
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Equilin Recovery: 
Average measured concentration: 383.364 ppb (n= 5) 
Fortified concentration: 400 ppb 
Percent Recovery: 95.8% 
 
Estrone Recovery: 
Average measured concentration: 345.720 ppb (n =5 ) 
Fortified Concentration: 400 ppb 
Percent Recovery: 86.4% 
 
EE2 Recovery: 
Average measured concentration: 649.306 ppb (n = 5) 
Fortified Concentration: 700 ppb 
Percent Recovery: 92.8% 
 
 
 
 
Estrogenic Compounds Detected 
 
Samples analyzed for estrogenic compounds were both influent (n=6) and effluent 
samples (n=6).  The concentrations detected in the LC/ESI-MS/MS were in ppb or μg/L, 
as these were samples concentrated and reconstituted to 1 ml, or concentrated 1000-fold.  
Although samples were analyzed for equilin, estrone, and EE2, only estrone was detected 
in influent and effluent samples (Table 3.1).  Results for estrone (ng/L) in the original 
samples indicated that influent samples typically had about two times or greater the 
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concentration as the effluent samples.  Accordingly, these results suggest that wastewater 
treatment had an effect on levels of estrone in effluent samples as compared to influent. 
 
Table 3.2. Concentration of Estrone detected in influent and effluent samples. 
Influent Sample 
ID 
Influent 
Estrone 
(ng/L) 
Effluent 
Sample ID 
Effluent 
Estrone 
(ng/L) 
Percent Difference 
(ppb) 
F001 19.055 F002 8.902 53.3 
F021 14.441 F022 < 1.0 * 100 
F031 14.122 F032 < 1.0 * 100 
F041 41.488 F042 3.886 90.6 
F051 14.346 F052 8.091 43.6 
F061 121.783 F062 17.711 85.5 
* Less than the limit of detection for the study per method and LC/ESI-MS/MS utilized. 
  
 To evaluate if there was a significant reduction in estrone concentrations (ng/L) in 
the effluent as compared the influent statistical analysis was performed.  Data were 
analyzed via IBM SPSS, Version 23 (2015).  Estrone concentration data were input into 
the SPSS system and exploratory data analysis was conducted to produce descriptive 
statistics and assess normality of each sample.  The sample mean for influent (n=6) and 
effluent (n=6) samples was 37.54 ng/L (SD=42.60 ng/L) and 7.27 ng/L (SD=5.82 ng/L).  
Exploratory data analysis, according to p-values for the Shapiro-Wilk test (α = .05), 
showed that the data for the effluent was normally distributed (p = .14), yet influent 
estrone levels were not (p = .002). 
 According to the results of the normality tests, nonparametric statistics were 
applied to compare the distribution of concentrations (ng/L) of estrone detected in the 
effluent versus the influent.  An Independent Samples Mann-Whitney U Test was used to 
compare the distributions.  This test was chosen because the data was not normally 
distributed and is more efficient on non-normal distributions than t-tests. Results of the 
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Mann-Whitney U Test (α = .05) indicated that the null hypothesis of equal distributions 
should be rejected (p = .015). Finally, as shown in Figure 3.1, the distribution of estrone 
detected in influent and effluent was significantly different.   
 
 
Figure 3.1. Boxplot of estrone (ng/L) in influent and effluent samples. 
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CHAPTER 4 
 
 
DISCUSSION 
 
 
 A matrix effect was present in the analysis of several of the influent waste water 
samples. This effect occurred because of the amount of solids and organic materials 
present in the influent samples. Although the influent samples were pre-filtered before 
extraction, it is theorized that there was a critical occurrence of microscopic particulates 
in these samples. These particulates caused may have caused ion suppression in the 
LC/ESI-MS/MS.  This interference was documented to be a problem in EPA Method 539 
(Ref). When there are a great number of competing ions, the instrument may become 
overloaded, and only able to identify few, if any, ions. This matrix effect caused an 
instrument defect, so much so that any hormones present in the samples could not be 
detected.  
This matrix effect can be seen through the measurement of the internal standard. 
The instrument was told that each sample contained 1000 ppb of EE2-d4, therefore the 
exact measurement of the internal standard was correct. However, the chromatogram 
curve of the internal standard is severely diminished in several of the influent samples, 
illustrating the matrix effect. As the average total percent recovery from the LCSs was 
over 90%, this effect was not a defect in the filtering or extraction process.  
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 Although this matrix effect was evident, a definitive answer to the hypothesis was 
determined for one of the estrogenic compounds, estrone. Accordingly, for estrone (ng/L) 
the H0 hypothesis was rejected (α = .05) and the Ha was accepted that the concentration 
(ng/L) of estrone in the influent was significantly different from concentrations in the 
effluent.  This significant difference is attributed to the treatment and removal of estrone 
from influent (ng/L) as compared to effluent (ng/L) samples.  
It is interesting to note that EE2 was not detected in any samples, other than those 
fortified with the surrogate. Typically, EE2 is the most persistent estrogen in the 
environment because of its synthetic characteristics (Clouzot, et al., 2008). The absence 
of EE2 could be for a variety of reasons, one being the matrix effect. Another possibility 
could be that synthetic hormones, like EE2, are from a different source that effluent 
discharges, as this hormone is given to livestock in nonorganic farms. The synthetic 
hormones previously detected in this watershed (Taylor & Grigsby, 2013) could have 
been partially from farming activities and nonpoint source runoff.  
 Estrone was the only estrogenic compound, of those this study was looking for, 
that was detected in the samples. Estrone is a natural hormone secreted by female ovaries 
and adipose tissue. The presence of this hormone is cause for concern, even though it is 
natural. Estrone is a known female carcinogen and can also cause cervical hypersecretion, 
menorrhagia, metrorrhagia, and hypertension. In men, estrone can cause feminization 
(“Estrone”, 2013).  
 
 Although not reported, during the analysis, bisphenol A (BPA) was found in 
every sample. This examination was not quantitative, as it only identified the presence of 
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BPA. Although EPA Method 539 recommended the use of a surrogate, such as BPA, it 
was beneficial that BPA was not used in this way. Had BPA been used as a surrogate, the 
recovery data would have been skewed because BPA was already present in the samples. 
Using the hormone mixture as a surrogate in blank samples was much more beneficial to 
measuring recovery.  
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CHAPTER 5 
 
 
CONCLUSION 
 
 
 Although the null hypothesis could not be adequately rejected for all estrogenic 
compounds measured, noteworthy information was gathered from this study.  
Specifically, a significant reduction of estrone (ng/L) was measured to occur in effluent 
samples versus influent samples. It can be hypothesized from the results that the 
wastewater treatment process did remove estrone (ng/L) from the influent. 
 The ion suppression that caused the matrix effect is most likely due to the drastic 
modification of EPA Method 539. This method was designed for drinking water, which is 
mostly free from solids and organic matter. This method was then modified for surface 
waters by adding a pre-filtration step before SPE. Finally, this study further modified the 
method for influent wastewater. The sheer amount of solids and organic materials present 
in the influent was theorized to be too great for a method designed for drinking water.  
Further studies should attempt to find an alternative method to analyze samples or 
attempt to prevent ion suppression and a matrix effect. Developing a method suited for 
influent wastewater is necessary to answer further research questions. If future studies 
can do this, it is possible to identify the exact process that removes estrogenic hormones 
during wastewater treatment. This information would be the first step to create a 
wastewater treatment processes that would remove multiple hormones from the influent 
and reduce or eliminate ecosystem exposure and health effects. 
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APPENDICES 
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Appendix A 
 
Below, the calibration curve reports for each hormone are shown. A linear plot indicates 
that the MS/MS is properly calibrated to measure the indicated material.  
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The chromatogram plots are shown below for equilin, estrone, and EE2. The first plot 
shows all three hormones plotted together. The three plots below show each hormone 
individually, respectively.  
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Appendix B 
The results from the analysis of the various concentrations of the surrogate are shown 
below.  
1/1.75 ppb: 
 
5/8.75 ppb: 
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10/17.5 ppb: 
 
100/175 ppb: 
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500/875 ppb: 
 
1000/1750 ppb: 
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Appendix C 
The 500 ppb calibration standard was analyzed before, during and after the samples. 
Below are the results of these analyses.  
Before: 
Mid Check: 
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End: 
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Appendix D 
The chromatogram plots from each sample are shown below. BPA was only analyzed 
qualitatively. The amount of BPA indicated on the chromatograms is not correct.  
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Appendix E 
 
The chromatogram plot for BPA calibration is shown below.  
 
 
 
